The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
IFITM5 mutations and osteogenesis imperfecta
Abstract
Interferon-induced transmembrane protein 5 (IFITM5) is an osteoblast-specific membrane protein that has been shown to be a positive regulatory factor for mineralization in vitro. However, Ifitm5 knockout mice do not exhibit serious bone abnormalities, and thus the function of IFITM5 in vivo remains unclear. Recently, a single point mutation (c.-14C>T) in the 5' untranslated region of IFITM5 was identified in patients with osteogenesis imperfecta type V (OI-V). Furthermore, a single point mutation (c.119C>T) in the coding region of IFITM5 was identified in OI patients with more severe symptoms than patients with OI-V. Although IFITM5 is not directly involved in the formation of bone in vivo, the reason why IFITM5 mutations cause OI remains a major mystery. In this review, the current state of knowledge of OI pathological mechanisms due to IFITM5 mutations will be reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFITM5 (Interferon-Induced Transmembrane Protein 5) encodes an osteoblast-specific membrane protein involved in bone mineralization 51 .”
From Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues (2026) · cites this paper as [51]
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Rauch, F., & Glorieux, F. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16051-0 · Cited by 1,167
An Acylation Cycle Regulates Localization and Activity of Palmitoylated Ras Isoforms
Rocks, O., Peyker, A., Kahms, M., Verveer, P. J., Koerner, C., Lumbierres, M., Kuhlmann, J., Waldmann, H., Wittinghofer, A., & Bastiaens, P. I. H. (2005) · Science · doi:10.1126/science.1105654 · Cited by 838
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 782
Marini, J. C., Forlino, A., Cabral, W. A., Barnes, A. M., San Antonio, J. D., Milgrom, S., Hyland, J. C., Körkkö, J., Prockop, D. J., De Paepe, A., et al. (2007) · Human Mutation · doi:10.1002/humu.20429 · Cited by 764
Palmitoylation of Intracellular Signaling Proteins: Regulation and Function
Smotrys, J. E., & Linder, M. E. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073954 · Cited by 610
Huang, I.-C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001258 · Cited by 603
CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta
Morello, R., Bertin, T. K., Chen, Y., Hicks, J., Tonachini, L., Monticone, M., Castagnola, P., Rauch, F., Glorieux, F. H., Vranka, J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.039 · Cited by 531
Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease
Glorieux, F. H., Rauch, F., Plotkin, H., Ward, L., Travers, R., Roughley, P., Lalic, L., Glorieux, D. F., Fassier, F., & Bishop, N. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1650 · Cited by 516
The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins
Rocks, O., Gerauer, M., Vartak, N., Koch, S., Huang, Z.-P., Pechlivanis, M., Kuhlmann, J., Brunsveld, L., Chandra, A., Ellinger, B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.007 · Cited by 454
Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect
Glorieux, F. H., Ward, L. M., Rauch, F., Lalic, L., Roughley, P. J., & Travers, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.30 · Cited by 446
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Feeley, E. M., Sims, J. S., John, S. P., Chin, C. R., Pertel, T., Chen, L.-M., Gaiha, G. D., Ryan, B. J., Donis, R. O., Elledge, S. J., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002337 · Cited by 387
Becker, J., Semler, O., Gilissen, C., Li, Y., Bolz, H. J., Giunta, C., Bergmann, C., Rohrbach, M., Koerber, F., Zimmermann, K., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.01.015 · Cited by 362
IFITM Proteins Restrict Viral Membrane Hemifusion
Li, K., Markosyan, R. M., Zheng, Y.-M., Golfetto, O., Bungart, B., Li, M., Ding, S., He, Y., Liang, C., Lee, J. C., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003124 · Cited by 358
Christiansen, H. E., Schwarze, U., Pyott, S. M., AlSwaid, A., Al Balwi, M., Alrasheed, S., Pepin, M. G., Weis, M. A., Eyre, D. R., & Byers, P. H. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.034 · Cited by 352
Alanay, Y., Avaygan, H., Camacho, N., Utine, G. E., Boduroglu, K., Aktas, D., Alikasifoglu, M., Tuncbilek, E., Orhan, D., Bakar, F. T., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.02.022 · Cited by 319
The human type I collagen mutation database
Dalgleish, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.181 · Cited by 313
PPIB Mutations Cause Severe Osteogenesis Imperfecta
van Dijk, F. S., Nesbitt, I. M., Zwikstra, E. H., Nikkels, P. G. J., Piersma, S. R., Fratantoni, S. A., Jimenez, C. R., Huizer, M., Morsman, A. C., Cobben, J. M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.001 · Cited by 298
Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway
Goodwin, J. S., Drake, K. R., Rogers, C., Wright, L., Lippincott-Schwartz, J., Philips, M. R., & Kenworthy, A. K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502063 · Cited by 294
Lapunzina, P., Aglan, M., Temtamy, S., Caparrós-Martín, J. A., Valencia, M., Letón, R., Martínez-Glez, V., Elhossini, R., Amr, K., Vilaboa, N., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.05.016 · Cited by 289
Mutations in WNT1 Cause Different Forms of Bone Fragility
Keupp, K., Beleggia, F., Kayserili, H., Barnes, A. M., Steiner, M., Semler, O., Fischer, B., Yigit, G., Janda, C. Y., Becker, J., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.010 · Cited by 289
A Single Recurrent Mutation in the 5′-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V
Cho, T.-J., Lee, K.-E., Lee, S.-K., Song, S. J., Kim, K. J., Jeon, D., Lee, G., Kim, H.-N., Lee, H. R., Eom, H.-H., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.005 · Cited by 265
Semler, O., Garbes, L., Keupp, K., Swan, D., Zimmermann, K., Becker, J., Iden, S., Wirth, B., Eysel, P., Koerber, F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.011 · Cited by 241
Ifitm3 Limits the Severity of Acute Influenza in Mice
Bailey, C. C., Huang, I.-C., Kam, C., & Farzan, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002909 · Cited by 231
Martínez-Glez, V., Valencia, M., Caparrós-Martín, J. A., Aglan, M., Temtamy, S., Tenorio, J., Pulido, V., Lindert, U., Rohrbach, M., Eyre, D., et al. (2012) · Human Mutation · doi:10.1002/humu.21647 · Cited by 219
The Human Collagen Mutation Database 1998
Dalgleish, R. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.253 · Cited by 218
The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential
Becerra, S. P., & Notario, V. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3484 · Cited by 211
Pyott, S. M., Tran, T. T., Leistritz, D. F., Pepin, M. G., Mendelsohn, N. J., Temme, R. T., Fernandez, B. A., Elsayed, S. M., Elsobky, E., Verma, I., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.009 · Cited by 208
Characterization of PEDF: A multi‐functional serpin family protein
Filleur, S., Nelius, T., de Riese, W., & Kennedy, R. C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22072 · Cited by 202
Mutations in WNT1 are a cause of osteogenesis imperfecta
Fahiminiya, S., Majewski, J., Mort, J., Moffatt, P., Glorieux, F. H., & Rauch, F. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101567 · Cited by 198
New Genes in Bone Development: What's New in Osteogenesis Imperfecta
Marini, J. C., & Blissett, A. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1505 · Cited by 197
Steinmann, B., Rao, V. H., Vogel, A., Bruckner, P., Gitzelmann, R., & Byers, P. H. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90631-9 · Cited by 195
Mutations in SERPINF1 cause osteogenesis imperfecta type VI
Homan, E. P., Rauch, F., Grafe, I., Lietman, C., Doll, J. A., Dawson, B., Bertin, T., Napierala, D., Morello, R., Gibbs, R., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.487 · Cited by 190
Mutations in FKBP10 cause recessive osteogenesis imperfecta and bruck syndrome
Kelley, B. P., Malfait, F., Bonafe, L., Baldridge, D., Homan, E., Symoens, S., Willaert, A., Elcioglu, N., Van Maldergem, L., Verellen-Dumoulin, C., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.250 · Cited by 188
Bril: A Novel Bone-Specific Modulator of Mineralization
Moffatt, P., Gaumond, M.-H., Salois, P., Sellin, K., Bessette, M.-C., Godin, É., de Oliveira, P. T., Atkins, G. J., Nanci, A., & Thomas, G. P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080412 · Cited by 182
Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta
Chu, M.-L., Williams, C. J., Pepe, G., Hirsch, J. L., Prockop, D. J., & Ramirez, F. (1983) · Nature · doi:10.1038/304078a0 · Cited by 178
Shaheen, R., Alazami, A. M., Alshammari, M. J., Faqeih, E., Alhashmi, N., Mousa, N., Al-Sinani, A., Ansari, S., Alzahrani, F., Al‐Owain, M. A., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101142 · Cited by 167
Sykes, B. C., Ogilvie, D., Wordsworth, B. P., Wallis, G. A., Mathew, C. G., Beighton, P., Nicholls, A. C., Pope, F. M., Thompson, E. M., & Tsipouras, P. (1990) · PubMed · Cited by 145
Altered Relation of Two Collagen Types in Osteogenesis Imperfecta
Sykes, B. C., Francis, M. J. O., & Smith, R. (1977) · New England Journal of Medicine · doi:10.1056/nejm197705262962104 · Cited by 140
Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase
Borg, M. L., Andrews, Z. B., Duh, E. J., Zechner, R., Meikle, P. J., & Watt, M. J. (2011) · Diabetes · doi:10.2337/db10-0845 · Cited by 139
Schwarze, U., Cundy, T., Pyott, S. M., Christiansen, H. E., Hegde, M., Bank, R. A., Pals, G., Ankala, A., Conneely, K. N., Seaver, L. H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds371 · Cited by 139
A Missense Mutation in the SERPINH1 Gene in Dachshunds with Osteogenesis Imperfecta
Drögemüller, C., Becker, D., Brunner, A., Haase, B., Kircher, P. R., Seeliger, F., Fehr, M., Baumann, U., Lindblad‐Toh, K., & Leeb, T. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000579 · Cited by 133
Hanagata, N., Li, X., Morita, H., Takemura, T., Li, J., & Minowa, T. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0221-0 · Cited by 131
Self-citationNormal Germ Line Establishment in Mice Carrying a Deletion of the Ifitm/Fragilis Gene Family Cluster
Lange, U. C., Adams, D. J., Lee, C. Y., Barton, S. C., Schneider, R., Bradley, A., & Surani, M. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00272-08 · Cited by 131
FKBP12 Binds to Acylated H-Ras and Promotes Depalmitoylation
Ahearn, I. M., Tsai, F. D., Court, H., Zhou, M., Jennings, B. C., Ahmed, M., Fehrenbacher, N., Linder, M. E., & Philips, M. R. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.001 · Cited by 127
Cohn, D. H., Byers, P. H., Steinmann, B. U., & Gelinas, R. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6045 · Cited by 120
Rauch, F., Moffatt, P., Cheung, M., Roughley, P. J., Lalic, L., Lund, A. M., Ramírez, N., Fahiminiya, S., Majewski, J., & Glorieux, F. H. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101307 · Cited by 116
Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen.
Trelstad, R. L., Rubin, D. A., & Gross, J. (1977) · PubMed · Cited by 104
Farber, C. R., Reich, A., Barnes, A. M., Becerra, P., Rauch, F., Cabral, W. A., Bae, A., Quinlan, A. R., Glorieux, F. H., Clemens, T. L., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2173 · Cited by 97
A Deletion Mutation in TMEM38B Associated with Autosomal Recessive Osteogenesis Imperfecta
Volodarsky, M., Markus, B., Cohen, I., Staretz‐Chacham, O., Flusser, H., Landau, D., Shelef, I., Langer, Y., & Birk, O. S. (2013) · Human Mutation · doi:10.1002/humu.22274 · Cited by 92
Takeda, Y., He, P., Tachibana, I., Zhou, B., Miyado, K., Kaneko, H., Suzuki, M., Minami, S., Iwasaki, T., Goya, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801902200 · Cited by 91
Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM 5 Mutation
Shapiro, J. R., Lietman, C., Grover, M., Lu, J. T., Nagamani, S. C. S., Dawson, B., Baldridge, D., Bainbridge, M. N., Cohn, D. H., Blazo, M., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1891 · Cited by 81
Natural History of Hyperplastic Callus Formation in Osteogenesis Imperfecta Type V
Cheung, M., Glorieux, F. H., & Rauch, F. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070418 · Cited by 77
Gattu, A. K., Swenson, E. S., Iwakiri, Y., Samuel, V. T., Troiano, N. W., Berry, R., CHURCH, C. D., Rodeheffer, M. S., Carpenter, T. O., & Chung, C. (2013) · The FASEB Journal · doi:10.1096/fj.13-232900 · Cited by 77
Li, F., Song, N., Tombran‐Tink, J., & Niyibizi, C. (2013) · Stem Cells · doi:10.1002/stem.1505 · Cited by 75
Zeitlin, L., Rauch, F., Travers, R., Munns, C. F., & Glorieux, F. H. (2005) · Bone · doi:10.1016/j.bone.2005.07.020 · Cited by 68
Connective tissue alterations in Fkbp10−/− mice
Lietman, C., Rajagopal, A., Homan, E. P., Munivez, E. M., Jiang, M., Bertin, T., Chen, Y., Hicks, J. M., Weis, M., Eyre, D. R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu197 · Cited by 62
A Mouse Model for Human Osteogenesis Imperfecta Type VI
Bogan, R., Riddle, R. C., Li, Z., Kumar, S., Nandal, A., Monier‐Faugere, M., Boskey, A. L., Crawford, S. E., & Clemens, T. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1892 · Cited by 61
Cabral, W. A., Barnes, A. M., Adeyemo, A., Cushing, K., Chitayat, D. A., Porter, F. D., Panny, S. R., Gulamali-Majid, F., Tishkoff, S. A., Rebbeck, T. R., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.2011.44 · Cited by 59
Hanagata, N., & Li, X. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.136 · Cited by 46
Self-citationRole of S-Palmitoylation on IFITM5 for the Interaction with FKBP11 in Osteoblast Cells
Tsukamoto, T., Li, X., Morita, H., Minowa, T., Aizawa, T., Hanagata, N., & Demura, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075831 · Cited by 45
Self-citationTwo mutations in IFITM5 causing distinct forms of osteogenesis imperfecta
Guillén‐Navarro, E., Ballesta‐Martínez, M. J., Valencia, M., Bueno, A. M., Martínez‐Glez, V., López‐González, V., Burnytė, B., Utkus, A., Lapunzina, P. D., & Ruiz‐Pérez, V. L. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36409 · Cited by 44
Type V OI Primary Osteoblasts Display Increased Mineralization Despite DecreasedCOL1A1Expression
Reich, A., Bae, A., Barnes, A. M., Cabral, W. A., Hinek, A., Stimec, J., Hill, S. C., Chitayat, D. A., & Marini, J. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3082 · Cited by 43
Hoyer‐Kuhn, H., Semler, O., Garbes, L., Zimmermann, K., Becker, J., Wollnik, B., Schöenau, E., & Netzer, C. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2156 · Cited by 42
A Transgenic Mouse Model of OI Type V Supports a Neomorphic Mechanism of the IFITM5 Mutation
Lietman, C., Marom, R., Munivez, E. M., Bertin, T., Jiang, M., Chen, Y., Dawson, B., Weis, M. A., Eyre, D. R., & Lee, B. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2363 · Cited by 41
Genotype–phenotype study in type V osteogenesis imperfecta
Balasubramanian, M., Parker, M. J., Dalton, A., Giunta, C., Lindert, U., Peres, L. C., Wagner, B. E., Arundel, P., Offiah, A. C., & Bishop, N. J. (2013) · Clinical Dysmorphology · doi:10.1097/mcd.0b013e32836032f0 · Cited by 39
Mutations in FKBP10 can cause a severe form of isolated Osteogenesis imperfecta
Steinlein, O. K., Aichinger, E., Trucks, H., & Sander, T. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-152 · Cited by 38
Patoine, A., Gaumond, M.-H., Jaiswal, P. K., Fassier, F. R., Rauch, F., & Moffatt, P. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2243 · Cited by 37
Kim, O.-H., Jin, D., Kosaki, K., Kim, J., Cho, S. Y., Yoo, W. J., Choi, I. H., Nishimura, G., Ikegawa, S., & Cho, T. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36024 · Cited by 37
Hanagata, N., Takemura, T., Monkawa, A., Ikoma, T., & Tanaka, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31240 · Cited by 35
Self-citationEngineered viruses to select genes encoding secreted and membrane-bound proteins in mammalian cells
Moffatt, P., Salois, P., Gaumond, M.-H., St-Amant, N., Godin, É., & Lanctôt, C. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf542 · Cited by 35
Arundel, P., Offiah, A. C., & Bishop, N. J. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.258 · Cited by 32
Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM 5 gene
Grover, M., Campeau, P. M., Lietman, C., Lu, J. T., Gibbs, R. A., Schlesinger, A. E., & Lee, B. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1983 · Cited by 28
Lazarus, S., McInerney-Leo, A. M., McKenzie, F. A., Baynam, G. S., Broley, S., Cavan, B. C. V., Munns, C. F., Pruijs, J. E. H., Sillence, D. O., Terhal, P. A., et al. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-107 · Cited by 24
A recurrent mutation in the 5′‐UTR of IFITM5 causes osteogenesis imperfecta type V
Takagi, M., Sato, S., Hara, K., Tani, C., Miyazaki, O., Nishimura, G., & Hasegawa, T. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36025 · Cited by 20
Phenotype and Genotype Analysis of Chinese Patients with Osteogenesis Imperfecta Type V
Zhang, Z., Li, M., He, J.-W., FU, W., Zhang, C.-Q., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072337 · Cited by 17
Fitzgerald, J., Holden, P. K., Wright, H., Wilmot, B., Hata, A., Steiner, R. D., & Basel, D. (2013) · PubMed · Cited by 14
Research works printed but not linked: 2
- Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Balwi MA, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389–398 · DOI · Paper page
- Campeau PM, Lee BH (2013) Phenotyic variability of osteogenesis imperfect type V caused by an IFITM5 mutation. J Bone Miner Res 28:1523–1530 · DOI
Cited by
Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types
Jovanovic, M., Guterman-Ram, G., & Marini, J. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab017 · Cited by 167
“The S40L BRIL mutation occurs near the palmitoylation sites at S50 and S51 (64) (Figure 3).”
BackgroundCollagen transport and related pathways in Osteogenesis Imperfecta
Claeys, L., Storoni, S., Eekhoff, E. M. W., Elting, M. W., Wisse, L. E., Pals, G., Bravenboer, N., Maugeri, A., & Micha, D. (2021) · Human Genetics · doi:10.1007/s00439-021-02302-2 · Cited by 131
“Mutations in these genes are mostly autosomal recessive; an exception to this are mutations in IFITM5 (autosomal dominant), PLS3 and MBTPS2 (recessive X-linked) (Hanagata 2016).”
BackgroundInfluentialPharmacological and biological therapeutic strategies for osteogenesis imperfecta
Marom, R., Lee, Y., Grafe, I., & Lee, B. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31532 · Cited by 72
“This mutation introduces a new start codon adding 5 amino acid residues to the IFITM5 protein, and is thought to have a neomorphic effect through unknown mechanisms [Lietman et al., 2015; Hanagata, 2016].”
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
Boudin, E., & Hul, W. V. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0990 · Cited by 45
Tüysüz, B., Elkanova, L., Alkaya, D. U., Güleç, Ç., Toksoy, G., Güneş, N., Yazan, H., Bayhan, A. I., Yıldırım, T., Yeşil, G., et al. (2021) · Bone · doi:10.1016/j.bone.2021.116293 · Cited by 36
Metadata
- Authors
- Hanagata, N.
- Affiliations
- Hokkaido University (JP)
- Corresponding author
- Hanagata, Nobutaka
- ORCID
- Hanagata, Nobutaka
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2015-06-02
- Volume
- 34
- Issue
- 2
- Pages
- 123-131
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W656739112
- Cited by
- 38
- References
- 79
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- IFITM5, osteogenesis imperfecta type V, osteogenesis imperfecta, genetic mutations, 5' untranslated region, osteoblasts, bone mineralization, interferon-induced transmembrane proteins, pathophysiological mechanisms
- MeSH terms
- Animals, Humans, Membrane Proteins, Mutation, Osteogenesis Imperfecta, Phenotype, Open Reading Frames
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.